Download PDF
Pharmacopsychiatry 2005; 38(6): 329-330
DOI: 10.1055/s-2005-916191
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Guillain-Barré Syndrome after Septicemia following Clozapine-Induced Agranulocytosis

A Case ReportJ. Mobascher1 , J. Zielasek1 , F. J. Schuier2 , A. Mobascher1 , R. Grohmann3 , M. W. Agelink4 , J. Cordes1
  • 1Department of Psychiatry and Psychotherapy, Heinrich-Heine University, Rhineland State Clinics, Düsseldorf, Germany
  • 2Department of Neurology, Heinrich-Heine University, Rhineland State Clinics, Düsseldorf, Germany
  • 3Department of Psychiatry and Psychotherapy, University of Munich, Munich, Germany
  • 4Department of Psychiatry, Psychotherapy and Psychosomatic, Herford, Germany
Further Information

Publication History

Received: 28.1.2005 Revised: 19.5.2005

Accepted: 2.8.2005

Publication Date:
08 December 2005 (online)

Also available at
    Permissions and Reprints

We report the case of a patient with schizophrenia, who experienced agranulocytosis during clozapine treatment, followed by bronchopulmonal infection and Guillain-Barré syndrome. The case was recorded within the German surveillance project ”drug safety in psychiatry” (AMSP) [2].

References

  • 1 Buchwald B, Ahangari R, Weishaupt A, Toyka K V. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barre syndrome.  Ann Neurol. 2002;  51 667-669
    CrossrefPubMedGoogle Scholar
  • 2 Grohmann R, Engel R R, Ruther E, Hippius H. The AMSP drug safety program: methods and global results.  Pharmacopsychiatry. 2004;  37 (Suppl 1) 4-11
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Hinze-Selch D, Becker E W, Stein G M, Berg P A, Mullington J, Holsboer F, Pollmächer T. Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients.  Neuropsychopharmacol. 1998;  19 114-122
    CrossrefPubMedGoogle Scholar
  • 4 Hinze-Selch D, Deuschle M, Weber B, Heuser I, Pollmächter T. Effect of coadministration of clozapine and fluvoxamine versus clozapine monotherapy on blood cell counts, plasma levels of cytokines and body weight.  Psychopharmacology. 2000;  149 163-169
    CrossrefPubMedGoogle Scholar
  • 5 Löffler S, Fehsel K, Henning U, Fischer J, Agelink M, Kolb-Bachofen V, Klimke A. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.  Pharmacopsychiatry. 2003;  36 37-41
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Toyka K V. Eighty three years of Guillain-Barre syndrome: clinical and immunopathologic aspects, current and future treatments.  Rev Neurol (Paris). 1999;  155 849-56
    PubMedGoogle Scholar
  • 7 Yuki N. Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes.  Lancet Infect Dis. 2001;  1 29-37
    CrossrefPubMedGoogle Scholar

Joachim Cordes, MD

Department of Psychiatry and Psychotherapy

Heinrich-Heine University

Bergische Landstr. 2

40629 Düsseldorf

Germany

Phone: +49 211 922 3402

Fax: +49 211 922 3615

Email: joachim.cordes@lvr.de

      >